What is Belviq?

Belviq is a weight-loss drug manufactured by the pharmaceutical company Eisai Inc. Belviq operates by activating receptors in the brain to stimulate the sensation of being full, resulting in a controlled appetite and decreased food consummation.

In February 2020, the FDA recalled the weight-loss drug Belviq by manufacturer Eisai, Inc. After the investigation, it was revealed that Belviq is linked to an increased risk of cancer among individuals who regularly take this weight loss drug.

FAQS

-What are the active ingredients in Belviq?

The active ingredient in Belviq is lorcaserin.

-Why was Belviq recalled?

In January 2020 the FDA announced the results of a 5-year clinical trial. The findings revealed that over an extensive period of time, patients using Belviq were diagnosed with cancer at a higher rate than those taking a placebo. Studies revealed that individuals taking the Belviq weight loss pill had a considerably higher risk of certain types of cancers, including:

-Why file a claim with us?

If you or someone you know has been diagnosed with the above cancers after taking the weight loss pill Belviq, it is crucial to hire an attorney who you can trust. We are your point of contact.

If you or a loved one have suffered as a result from Belviq, contact us.